Cabin1 restrains p53 activity on chromatin

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• The tumor suppressor p53 is a key regulator of cellular responses to genotoxic stress.
• p53 is known to bind target promoters upon DNA damage, but its presence on some promoters without stress suggests regulation by inhibitors.
• Understanding p53 regulation is crucial for cancer therapy development.

Purpose of the Study:

• To identify negative regulators of p53 transcriptional activity in the absence of genotoxic stress.
• To elucidate the mechanism by which p53 activity is repressed in quiescent cells.
• To investigate the role of Cabin1 in p53-mediated gene regulation and cellular response to DNA damage.

Main Methods:

• Co-immunoprecipitation to demonstrate physical interaction between p53 and Cabin1.
• Chromatin immunoprecipitation followed by sequencing (ChIP-seq) to map p53 and Cabin1 occupancy on target promoters.
• Histone modification analysis (e.g., acetylation) and p53 acetylation assays.
• Gene expression analysis (e.g., qRT-PCR, Western blotting) to assess p53 target gene activation.
• Cell growth and viability assays following Cabin1 knockdown and DNA damage induction.

Main Results:

• Calcineurin binding protein 1 (Cabin1) was identified as a negative regulator of p53.
• Cabin1 physically interacts with p53 on specific target promoters, repressing its transcriptional activity.
• Cabin1 regulates histone modifications and p53 acetylation, contributing to transcriptional repression in quiescent cells.
• Downregulation of Cabin1 leads to the activation of a subset of p53 target genes.
• Cabin1 knockdown enhances p53-dependent cell growth retardation and cell death following DNA damage.

Conclusions:

• Cabin1 acts as a critical inhibitor of p53 function on chromatin in the quiescent state.
• The repression of p53 by Cabin1 allows for the maintenance of inactive p53 on promoters, facilitating a prompt cellular response upon DNA damage.
• Targeting the Cabin1-p53 interaction could be a potential therapeutic strategy in cancer treatment.